home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

Down's Syndrome

  March, 29 2006 9:19
your information resource in human molecular genetics
Down's syndrome is caused by having three (rather than two) copies of chromosome 21, but researchers know little about how a 1.5-fold increase in gene dosage on this chromosome triggers the various developmental problems associated with Down's syndrome.

In a study published online by Nature, Gerald Crabtree and his colleagues make an important step towards answering that question. They show that two genes on chromosome 21, called DSCR1 and DYRK1A, work together to export from the cell nucleus - and reduce the activity of - a group of NFAT proteins that are critical for gene regulation during vertebrate growth and development.

The authors found that mice with mutations in Nfat genes show many of the characteristics of Down's syndrome. NFAT proteins normally operate under a positive feedback loop, enhancing their own production. The researchers used mathematical modelling and studies of genetically engineered mice to show that a 1.5-fold increase in DSCR1 and DYRK1A gene dosage produces a disproportionately large reduction in NFAT activity. The feedback loop means that an initially small reduction in NFAT grows into a larger one, leading to decreased activation of NFAT target genes.


Gerald Crabtree (Stanford University School of Medicine, Stanford, CA, USA)
E-mail: crabtree@stanford.edu

Abstract available online.

(C) Nature press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.